Breast Cancer News and Research

Latest Breast Cancer News and Research

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Endo Pharmaceuticals announced that FORTESTA Gel – recently approved by the U.S. Food and Drug Administration for the treatment of low testosterone, or 'Low T' in adult males – is now available by prescription in pharmacies across the country.

3 Mar 2011

Scientists uncover genetic pathway that affects breast cancer development

Using recent advances in genomics, researchers have uncovered a genetic pathway that affects the development of breast cancer, work that could help predict which patients are at risk of relapse for the disease.

3 Mar 2011

Rural women seek breast cancer screenings for the good of their families

A new study published in the Journal of Consumer Affairs finds that women from rural populations are motivated to seek breast cancer prevention screenings primarily out of concern for the long-term well being of their families. The study shows that by appealing to their strength as caretakers doctors can encourage their rural patients to perform breast health self-examinations, get mammograms, and to talk with doctors about their breast health.

3 Mar 2011

EU's Avastin policy: A stark contrast to the FDA's recent decision

The committee's decision stands in stark contrast to the recent verdict by the U.S. Food and Drug Administration, which is wary of Avastin's benefits for breast-cancer patients.

3 Mar 2011

ContextVision launches MAMMO PlusViewCAD breast cancer detection tool at ECR

ContextVision is pleased to a announce that today at the ECR in Vienna, it is officially launching the first product stemming from its recently announced strategic alliance with NeuSoft Medical Technologies.

3 Mar 2011

Eisai announces publication of Halaven Phase III study results against breast cancer in The Lancet journal

Eisai announced today that results from the global Phase III clinical study "EMBRACE" will be published online in The Lancet.

3 Mar 2011

ContextVision launches two breast cancer diagnostic imaging solutions at ECR 2011

ContextVision, the software imaging partner for the most recognized medical imaging manufacturers worldwide, today introduced two innovative solutions at the 2011 European Congress of Radiology.

3 Mar 2011

iCAD to showcase its cancer diagnostic imaging products at ECR annual meeting

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology's annual meeting being held in Vienna, Austria from March 3 - 7, 2011.

3 Mar 2011

U-M scientists identify potential target to treat aggressive prostate cancer

Researchers at the University of Michigan Comprehensive Cancer Center have identified a potential target to treat an aggressive type of prostate cancer. The target, a gene called SPINK1, could be to prostate cancer what HER2 has become for breast cancer.

3 Mar 2011

Naviscan launches PEM breast cancer scanner in Europe

Naviscan, Inc., announces the European launch of the Naviscan Positron Emission Mammography scanner at two prestigious radiology conferences in Vienna.

3 Mar 2011

Women smokers over 50 at increased risk of breast cancer

Compared to women who had never smoked, breast cancer risk increased by nine percent among former smokers and by 16 percent among current smokers according to research by Karen Margolis, MD, a senior clinical investigator with the HealthPartners Research Foundation and her collaborators in a study that was published today in the British Medical Journal.

3 Mar 2011

BigThink.com launches breakthroughs: Discussion highlighting cutting-edge cancer research

Everyone knows someone that has been touched by cancer. Over one and a half million Americans will be diagnosed with some form of cancer in 2011, and more than 560,000 will die from the disease, accounting for 1 out of every 5 deaths.

2 Mar 2011

Research: Blocking two cell DNA repair routes at once can provide new way to treat bowel cancer

Cancer Research UK-funded scientists have discovered that blocking two cell DNA repair routes at once could provide a completely new way to treat bowel cancer and potentially other cancers, according to research published in Cancer Research, today.

2 Mar 2011

NCI sponsors multi-center phase 2 study of entinostat-anastrozole combination in triple negative breast cancer

Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, announced the National Cancer Institute (NCI) will sponsor a multi-center phase 2 study of Syndax's lead product entinostat, a novel inhibitor of histone deacetylases (HDAC), and anastrozole, an aromatase inhibitor, in postmenopausal women with operable triple negative breast cancer to evaluate biomarkers and surrogates for response.

2 Mar 2011

Study confirms risk of triple-negative breast cancer among obese, physically inactive women

New findings published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, confirm the risk of breast cancer among women who are obese and not physically active, and suggests additional mechanisms beyond estrogen.

1 Mar 2011

New study: No decline in breast cancer incidence rates among U.S. white women

A sharp decline in breast cancer incidence rates among non-Hispanic white women in the U.S. after a dramatic drop in the use of postmenopausal hormone therapy did not continue through 2007, according to a new study from the American Cancer Society and the National Cancer Institute.

1 Mar 2011

Axolotl's two EHR systems receive ONC-ATCB certification

Axolotl Corp. announced that two of its electronic health record systems - Axolotl EHR, version 7 and Elysium EMR Lite - have received Office of the National Coordinator for Health IT Authorized Testing and Certification Body 2011/2012 certifications in accordance with Eligible Provider certification criteria adopted by the U.S. Department of Health and Human Services.

1 Mar 2011

Leptin receptor antagonist peptide demonstrates efficacy against triple negative breast cancer

A new peptide developed by researchers in Temple University's College of Science and Technology has demonstrated efficacy against triple negative breast cancer.

1 Mar 2011

Daiichi Sankyo enters merger agreement to acquire Plexxikon

Plexxikon Inc. today announced it has entered into a merger agreement with Daiichi Sankyo Company, Limited, a Japan-based global pharmaceutical company.

28 Feb 2011

TCD announces first patient treated in its TCD-717 Phase I trial

Traslational Cancer Drugs Pharma, S.L. (“TCD”) announced today that the first patient was treated on Friday the 18th of February with TCD-717 in a Phase I study performed in patients with advanced solid tumors. TCD-717 is a first-in-class, small molecule that precisely inhibits Choline Kinase Alpha, an enzyme heavily involved in the carcinogenic process. A total of 30 patients are planned to be treated in the trial, which will be conducted in accordance with FDA approval, in two leading medical centers in the U.S. The Principal Investigators are Dr. Julie Brahmer at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital in Baltimore; and Dr. Patricia LoRusso at the Barbara Ann Karmanos Cancer Institute in Detroit.

28 Feb 2011

Breast Cancer News and Research

Latest Breast Cancer News and Research

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Scientists uncover genetic pathway that affects breast cancer development

Rural women seek breast cancer screenings for the good of their families

EU's Avastin policy: A stark contrast to the FDA's recent decision

ContextVision launches MAMMO PlusViewCAD breast cancer detection tool at ECR

Eisai announces publication of Halaven Phase III study results against breast cancer in The Lancet journal

ContextVision launches two breast cancer diagnostic imaging solutions at ECR 2011

iCAD to showcase its cancer diagnostic imaging products at ECR annual meeting

U-M scientists identify potential target to treat aggressive prostate cancer

Naviscan launches PEM breast cancer scanner in Europe

Women smokers over 50 at increased risk of breast cancer

BigThink.com launches breakthroughs: Discussion highlighting cutting-edge cancer research

Research: Blocking two cell DNA repair routes at once can provide new way to treat bowel cancer

NCI sponsors multi-center phase 2 study of entinostat-anastrozole combination in triple negative breast cancer

Study confirms risk of triple-negative breast cancer among obese, physically inactive women

New study: No decline in breast cancer incidence rates among U.S. white women

Axolotl's two EHR systems receive ONC-ATCB certification

Leptin receptor antagonist peptide demonstrates efficacy against triple negative breast cancer

Daiichi Sankyo enters merger agreement to acquire Plexxikon

TCD announces first patient treated in its TCD-717 Phase I trial

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in